For instance, in 2006, Iizuka et al. described that cfDNA levels were elevated in patients with hepatitis C virus (HCV)-associated HCC, and its diagnostic power was superior to that of serum AFP [94]. This evidence concerns the gene AFP and hepatocellular carcinoma.